Halozyme Reports Third Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Halozyme Reports Third Quarter 2016 Financial Results

Halozyme Therapeutics (HALO) Tops Q3 EPS by 4c

November 7, 2016 4:29 PM EST

Halozyme Therapeutics (NASDAQ: HALO) reported Q3 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $31.9 million versus the consensus estimate of $33.86 million.

GUIDANCE:

Halozyme Therapeutics sees 2016 revenue of $145-150 million, versus the consensus of $146.6... More